Psychosis in a methadodone-substituted patient during interferon-alpha treatment of hepatitis C

Addiction

Volumn 95, Issue 7, 2000, Pages 1101-1104

  Schäfer, Martin ^a   Boetsch, Thomas ^a   Laakmann, Gregor ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; METHADONE; ANTIVIRUS AGENT; NARCOTIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DEPRESSION; DRUG ABUSE; DRUG SAFETY; HEPATITIS C; HUMAN; MALE; MANIA; PSYCHOSIS; SUICIDAL BEHAVIOR; TREATMENT CONTRAINDICATION; DRUG CONTRAINDICATION;

ADULT; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; METHADONE; NARCOTICS; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 0033624493     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2000.957110111.x     Document Type: Article

References (21)

1. ADAMS, F., QUESADA, J., GUTTERMAN, J. (1984) Neuropsychiatric manifestation of human leukocyte interferon therapy in patients with cancer, Journal of the American Medical Association, 252, 938-941.
2. CABRERA GOMEZ, J. A., GUTIERREZ, J. R., LOPEZ, O., GUITIEREZ, B., GARCIA, K., CONSUEGRA, J., CRUZ, R., QUEVEDO, A., CAPDEGILLE, I., FALCON, M., SERRANO, S., GALINDO, M., SAURA, P. & RIVERO, Y. (1994) Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b Interferon, Biotherapy, 7, 27-37.
3. CIRELLI, R. & TYRING, S. K. (1995) Major therapeutic use of interferons, Clinical Immunotherapeutics, 3, 27-87.
4. GAUDIN, J. L., FAURE, P., GODINOT, H., GERARD, F. & TREPO, C. (1995) The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Result of a randomized controlled trial, Liver, 15, 45-52.
5. GUTTERMAN, J. U. (1994) Cytokine therapeutics: lessons from interferon-alpha, Proceedings of the National Academy of Science USA, 91, 1198-1205.
6. HARIA, M. & BENFIELD, P. (1995) Interferon-alpha-2a, Drugs, 50, 873-896.
7. HENDRIK, A. (1994) Psychosis during interferon in eosinophilic leukemia, Clinical and Laboratory Haematology, 16, 295-296.
8. HERESCO-LEVI, U. & JAVITT, D. C. (1998) The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes, European Neuropsychopharmacology, 8, 141-152.
9. JANSSEN, H. L. A., BROUWER, J. T., VAN DER MAST, R. C. & SCHALM, S. W. (1994) Suicide associated with alpha-interferon therapy for chronic viral hepatitis, Journal of Hepatology, 21, 241-243.
10. KATAFUCHI, T., TAKE, S. & HORI, T. (1995) Roles of cytokines in the neural immune interactions: modulation of NMDA-responses by IFN-alpha, Neurobiology, 3, 319-327.
11. LEVENSON, J. L. & FALLON, H. J. (1993) Fluoxetine treatment of depression caused by interferon-alpha, American Journal of Gastroenterology, 88, 760-761.
12. MCDONALD, E. M., MANN A. H. & THOMAS, H. C. (1987) Interferons as mediators of psychiatric morbidity, Lancet, 2, 1175-1178.
13. MELDRUM, B. & GARTHWAITE, J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends in Pharmacological Science, 11, 379-387.
14. MERIMSKY, O. & CHAITCHIK, S. (1992) Neurotoxicity of interferon-alpha, Anti-Cancer Drug, 3, 567-570.
15. MURAOKA, H., SANEFUJI, T., KEIDA, R., TSUJI, R., ABE, H., UCHIMURA, Y., SATA, M., TANIKAWA, K., NOSE, I., UCHIMURA, N. & NAKAZAWA, Y. (1996) A patient with chronic hepatitis C and a history of abuse of analeptic drugs, who showed hallucination und delusion with interferon administration, Kurume Medical Journal, 43, 73-77.
16. PARIANTE, C. M., ORRU, M. G., BAITA, A., FARCI, M. G. & CARPNICELLO, B. (1999) Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders, Lancet, 10, 131-132.
17. RENAULT, P. F., HOOFNAGLE, J. H., PARK, Y., MULLEN, K. D., PETERS, M., JONES, B., RUSTGI, V. & JONES, A. (1987) Psychiatric complications of long-term interferon alpha therapy, Archives of Internal Medicine, 147, 1577-1580.
18. RENAULT, P. F. & HOOFNAGLE, J. H. (1989) Side effects of alpha interferon, Seminars in Liver Disease 9, 273-277.
19. ROUNSAVILLE, B. J., WEISSMANN, M. M., KLEBER, H. D. & WILBER, C. (1982) Heterogenity of psychiatric diagnosis in treated opiate addicts, Archives of General Psychiatry, 39, 161-166.
20. VALENTINE, A. D., MEYERS, C. A., KLING, M. A., RICHELSON, E. & HAUSER, P. (1998) Mood and cognitive side effects of interferon-alpha therapy, Seminars in Oncology, 25, 39-47.
21. VAN THIEL, D. H., FRIEDLANDER, L., MOLLOY, P. J., FAGIUOLI, S., KANIA, R. J. & CARACENI, P. (1995) Interferon-alpha can be successfully in patients with hepatitis C virus-positive chronic hepatitis who have psychiatric illness, European Journal of Gastroenterology and Hepatology, 7, 165-168.